Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Receptor Activation
100%
Mycobacterium Tuberculosis (M. tb)
100%
Pregnane X Receptor
100%
HIV Co-infection
100%
Tuberculosis Treatment
100%
Tuberculosis Coinfection
100%
Rifamycin
37%
Rifampin
25%
Nonreplicating Persisters
25%
Health Problems
12%
Design Approach
12%
AIDS/HIV
12%
Time-to-treatment
12%
Dimethyl Sulfoxide
12%
40 Years Old
12%
Bacterial RNA Polymerase
12%
Treatment Duration
12%
Tuberculosis
12%
Current Treatment
12%
Chemotype
12%
Short-term Treatment
12%
Death Rate
12%
Cytochrome P450 3A4 (CYP3A4)
12%
World Health
12%
Mycobacterium Tuberculosis Strains
12%
Ansamycins
12%
Structure-based Drug Design
12%
Rifalazil
12%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Pregnane X Receptor
100%
Mycobacterium Tuberculosis
100%
Mixed Infection
100%
Rifamycin
33%
Rifampicin
22%
Drug Development
11%
Dimethyl Sulfoxide
11%
Cytochrome P450
11%
RNA Polymerase
11%
Bacterial RNA
11%
CYP3A4
11%
Diseases
11%
Rifalazil
11%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Coinfection
100%
Mycobacterium Tuberculosis
100%
Rifamycin
33%
Cytochrome P450
22%
Wild Type
11%
Bactericidal Activity
11%
RNA Polymerase
11%
Chemotype
11%
Global Health
11%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Pregnane X Receptor
100%
Mycobacterium Tuberculosis
100%
Wild Type
11%
Bactericidal Activity
11%
RNA Polymerase
11%
Dimethyl Sulfoxide
11%
Global Health
11%
CYP3A4
11%
Cytochrome P450
11%